Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia.
about
Heparin induced thrombocytopenia in critically ill: Diagnostic dilemmas and management conundrumsA difficult diagnosis case of prolonged thrombocytopenia with sepsis and disseminated intravascular coagulation.Low allergenic potential with fondaparinux: results of a prospective investigation.Fondaparinux: does it cause HIT? Can it treat HIT?Heparin-induced thrombocytopenia: evaluation of IgG and IgGAM ELISA assays.Utility of ELISA optical density values and clinical scores for the diagnosis of and thrombosis prediction in heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia: present and future.HIT paradigms and paradoxes.Rapid and simple IgG specific test for the exclusion of heparin induced thrombocytopenia (HIT).Rapid exclusion or confirmation of heparin-induced thrombocytopenia: a single-center experience with 1,291 patients.Autoantibody-mediated complement activation on platelets is a common finding in patients with immune thrombocytopenic purpura (ITP).Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Argatroban therapy for heparin-induced thrombocytopenia during pregnancy in a woman with hereditary antithrombin deficiency.PF4/heparin antibody testing and treatment of heparin-induced thrombocytopenia in the intensive care unit.Evaluation of two new automated chemiluminescent assays (HemosIL® AcuStar HIT-IgG and HemosIL® AcuStar HIT-Ab) for the detection of heparin-induced antibodies in the diagnosis of heparin-induced thrombocytopenia.Management of heparin-induced thrombocytopenia.Antithrombotic therapy in heparin-induced thrombocytopenia: guidelines translated for the clinician.Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.Antigen and substrate withdrawal in the management of autoimmune thrombotic disorders.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.Heparin-induced thrombocytopenia following hip and knee arthroplasty.Novel diagnostic assays for heparin-induced thrombocytopeniaFcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia.Alternative diagnosis to heparin-induced thrombocytopenia in two critically ill patients despite a positive PF4/heparin-antibody testPlatelet factor 4/heparin-particle gel immunoassay (PaGIA) is a weak method for heparin-induced thrombocytopenia (HIT) evaluation of post cardio-pulmonary bypass surgery patients.Current insights into the laboratory diagnosis of HIT.Progressive thrombocytopenia after cardiac surgery in a 67-year-old man.Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia.Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.Over-testing for heparin induced thrombocytopenia in hospitalized patients.An update on heparin-induced thrombocytopenia: diagnosis and management.Evaluation of a flow cytometric assay for the confirmation of heparin-induced thrombocytopenia.The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.Diagnostic accuracy of IgG-specific versus polyspecific enzyme-linked immunoassays in heparin-induced thrombocytopenia: a systematic review and meta-analysis.Rapid immunoassays for diagnosis of heparin-induced thrombocytopenia: Comparison of diagnostic accuracy, reproducibility, and costs in clinical practice.Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.Platelet factor 4/heparin antibodies in blood bank donors.
P2860
Q26799395-A648EBFD-381B-4261-8265-73AC46D5D542Q33389979-6F1741DB-002D-4FEF-A384-91C84AE29E81Q33391886-3D1958A8-6B24-4A42-B390-5FC49CA1BDCFQ33392864-3EC845F5-4638-4B72-9EF2-43A2F0538E9CQ33393048-E7488B66-03F7-4746-A728-F63D3AD1A78AQ33393683-0A258FFA-FE1F-4BA4-9496-83DF96077791Q33394188-3AE87FB3-B3CD-4193-9752-DF0168DA8E46Q33396313-08851296-FC9F-4A8A-9627-0F2AF2968B3EQ33396893-0776009E-1AF5-4EFD-88AE-BA705F21778AQ33397294-8EDD7242-9733-4C9F-9C91-15B525A9604DQ33397553-EE5FB4B9-C9D4-4008-89D4-C65775E19DC9Q33398047-6AACB236-CE96-4F82-B4CE-AC57613C61C6Q33399580-D258F585-F668-431F-9496-B31B4F954998Q33400008-A150B2B9-1066-4B23-B28F-5005799526B8Q33400056-54A11A33-46E3-464F-BB2F-41FA3C1B5712Q33400181-6BDBC4B6-4E87-4753-ADFA-7C34A774CE80Q33400573-EFC58C00-25BC-44F0-A58D-452199111312Q33402572-5A2E8455-24D0-4980-BEA0-2F27986D329BQ33403113-55D84B67-1072-40F6-BF4F-ED2B2414DB38Q33403225-74E3D2E3-A92D-4E42-8D10-6E93A706AD42Q33403395-389D132D-D4D4-47BE-B041-47CE6309B225Q33405846-7BBCCBB8-0F05-47A0-BBCC-2710DC83B0DBQ33406133-2D5EF961-C820-4D86-8F2D-FD9521FEF32CQ33406804-929F69E7-23E8-42EE-BA9C-14987B33CDAFQ33407198-16D808F5-15F4-4569-80BD-CFFAF26A2478Q33410801-2C9B224F-36F8-4A52-BCCF-6D2A84B197D8Q33413476-E1754185-B30A-46CA-B03C-5F022737662CQ33414746-6490F380-C6DE-407F-8541-A5B1135FA4BEQ33414796-A30358BC-11A9-482F-85D6-6C87A8593412Q33415202-D1420BE0-73F6-49AE-8E26-ED363A32720BQ33416315-CF816C76-45AA-4B2A-9F9C-0AA78E07E4B9Q33417093-1601824F-EABD-4FBF-90A9-C3884E2F8008Q33430644-9E9B1CFC-ECBC-4FC4-97A1-495D0BA4CB0FQ33430846-A11029A3-73CC-4A58-AB92-E5EE964062DDQ33435819-E0B8A173-D58D-4E20-B19A-1D17F3C45F27Q33440663-45B90F57-4D16-4040-B306-091FD702966CQ33442535-BF2BF2C8-8E8A-47BC-BAC9-2B7AC23EF219Q33442746-DFA09B7D-C9F1-4679-BC62-E321E6B579CAQ33453074-F6E20D71-1595-4AA6-B9B9-8E66CC10C67D
P2860
Prospective evaluation of PF4/heparin immunoassays for the diagnosis of heparin-induced thrombocytopenia.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@ast
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@en
type
label
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@ast
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@en
prefLabel
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@ast
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@en
P2093
P1476
Prospective evaluation of PF4/ ...... arin-induced thrombocytopenia.
@en
P2093
P304
P356
10.1111/J.1538-7836.2009.03465.X
P577
2009-04-30T00:00:00Z